Calcimedica Common Stock Stock Performance

CALC Stock   0.61  0.01  0.82%   
The firm shows a Beta (market volatility) of -0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CalciMedica Common are expected to decrease at a much lower rate. During the bear market, CalciMedica Common is likely to outperform the market. At this point, CalciMedica Common Stock has a negative expected return of -1.24%. Please make sure to confirm CalciMedica Common's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if CalciMedica Common Stock performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days CalciMedica Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor
1:14
Last Split Date
2023-03-20
1
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical Corporate Updates
11/12/2025
2
Stonepine Capital Management LLC Has 136,000 Stock Position in CalciMedica Inc. CALC - MarketBeat
12/05/2025
3
How CalciMedica Inc. stock reacts to global recession fears - 2025 Growth vs Value Fast Moving Stock Watchlists - ulpravda.ru
01/08/2026
4
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
01/28/2026
Begin Period Cash Flow5.5 M
Total Cashflows From Investing Activities-4.4 M

CalciMedica Common Relative Risk vs. Return Landscape

If you would invest  306.00  in CalciMedica Common Stock on November 8, 2025 and sell it today you would lose (245.00) from holding CalciMedica Common Stock or give up 80.07% of portfolio value over 90 days. CalciMedica Common Stock is currently does not generate positive expected returns and assumes 12.9846% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CalciMedica, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days CalciMedica Common is expected to under-perform the market. In addition to that, the company is 16.97 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

CalciMedica Common Target Price Odds to finish over Current Price

The tendency of CalciMedica Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.62 90 days 0.62 
about 99.0
Based on a normal probability distribution, the odds of CalciMedica Common to move above the current price in 90 days from now is about 99.0 (This CalciMedica Common Stock probability density function shows the probability of CalciMedica Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days CalciMedica Common Stock has a beta of -0.59 suggesting as returns on the benchmark increase, returns on holding CalciMedica Common are expected to decrease at a much lower rate. During a bear market, however, CalciMedica Common Stock is likely to outperform the market. Additionally CalciMedica Common Stock has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   CalciMedica Common Price Density   
       Price  

Predictive Modules for CalciMedica Common

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CalciMedica Common Stock. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.030.6313.61
Details
Intrinsic
Valuation
LowRealHigh
0.193.8716.85
Details
4 Analysts
Consensus
LowTargetHigh
12.4413.6715.17
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.49-0.43-0.37
Details

CalciMedica Common Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. CalciMedica Common is not an exception. The market had few large corrections towards the CalciMedica Common's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CalciMedica Common Stock, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CalciMedica Common within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.07
β
Beta against Dow Jones-0.59
σ
Overall volatility
1.61
Ir
Information ratio -0.09

CalciMedica Common Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CalciMedica Common for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CalciMedica Common Stock can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
CalciMedica Common generated a negative expected return over the last 90 days
CalciMedica Common has high historical volatility and very poor performance
CalciMedica Common has some characteristics of a very speculative penny stock
CalciMedica Common has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (13.7 M) with profit before overhead, payroll, taxes, and interest of 0.
CalciMedica Common generates negative cash flow from operations
CalciMedica Common has a frail financial position based on the latest SEC disclosures
About 56.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

CalciMedica Common Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CalciMedica Stock often depends not only on the future outlook of the current and potential CalciMedica Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CalciMedica Common's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding11.2 M
Cash And Short Term Investments18.7 M

CalciMedica Common Fundamentals Growth

CalciMedica Stock prices reflect investors' perceptions of the future prospects and financial health of CalciMedica Common, and CalciMedica Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CalciMedica Stock performance.

About CalciMedica Common Performance

By analyzing CalciMedica Common's fundamental ratios, stakeholders can gain valuable insights into CalciMedica Common's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CalciMedica Common has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CalciMedica Common has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand(13.29)(13.96)
Return On Tangible Assets(0.80)(0.84)
Return On Capital Employed(1.35)(1.28)
Return On Assets(0.80)(0.84)
Return On Equity(1.09)(1.15)

Things to note about CalciMedica Common Stock performance evaluation

Checking the ongoing alerts about CalciMedica Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CalciMedica Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
CalciMedica Common generated a negative expected return over the last 90 days
CalciMedica Common has high historical volatility and very poor performance
CalciMedica Common has some characteristics of a very speculative penny stock
CalciMedica Common has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (13.7 M) with profit before overhead, payroll, taxes, and interest of 0.
CalciMedica Common generates negative cash flow from operations
CalciMedica Common has a frail financial position based on the latest SEC disclosures
About 56.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
Evaluating CalciMedica Common's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate CalciMedica Common's stock performance include:
  • Analyzing CalciMedica Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CalciMedica Common's stock is overvalued or undervalued compared to its peers.
  • Examining CalciMedica Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating CalciMedica Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CalciMedica Common's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of CalciMedica Common's stock. These opinions can provide insight into CalciMedica Common's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating CalciMedica Common's stock performance is not an exact science, and many factors can impact CalciMedica Common's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for CalciMedica Stock analysis

When running CalciMedica Common's price analysis, check to measure CalciMedica Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica Common is operating at the current time. Most of CalciMedica Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica Common's price. Additionally, you may evaluate how the addition of CalciMedica Common to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing